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glossia, excessive caries, premature loss of teeth and microstomia 
( fig. 1 e). The patient also complained of ocular pain, which was 
in agreement with the findings of blisters, erosions and scarring 
of the cornea on ophthalmic examination ( fig. 1 f). She presented 
other physical deformities, such as joint contractures, and exhib-
ited esophageal strictures, chronic anemia and growth retarda-
tion. 
 Since the age of 33 years, she had undergone repeated surgical 
interventions for the excision of primary and recurrent squamous 
cell carcinomas (SCC) of both hands/arms ( fig. 1 g) and of the left 
foot and leg. In all cases, histopathological examination showed 
well to moderately differentiated SCC ( fig. 1 h, i), as usually de-
scribed in RDEB patients. At the time of the last surgery, com-
plete staging investigations – including ultrasound, CT and PET 
scans – were negative. Following written informed consent, skin 
and blood samples were obtained from the patient. Routine his-
tological examination of a skin biopsy showed subepidermal blis-
ters and indirect immunofluorescence, using the monoclonal an-
tibody LH7.2, complete absence of VII collagen protein ( fig. 1 j, k) 
in accordance with the clinical presentation. Genomic DNA was 
extracted from peripheral blood lymphocytes of the patient and 
her parents by standard methods, and mutations were identified 
and characterized by PCR amplification and direct sequencing 
as described previously  [3] . The patient was a heterozygous 
carrier for the R1763X mutation located in exon 60 and the 
c.6266delCCCC mutation (also designated as c.6266_6269del) lo-
cated in exon 75 ( fig. 2 a) and predicted to result in a frameshift 
and a stop codon in exon 82. Thus, the patient bore two prema-
ture-termination-codon-causing mutations in her  COL7A1. Fur-
ther mutation analysis in the patient’s parents revealed that the 
mother was a carrier of the c.6266delCCCC mutation, this dele-
tion has already been reported by our group in this patient [pa-
tient No. 25 in reference  3 ]; however, the second disease-causing 
mutation (the de novo mutation) had not been disclosed at that 
time. In contrast, the father did not carry either mutation, sug-
gesting that the p.R1763X mutation occurred de novo on the pa-
ternal allele. Paternity was therefore confirmed by human leuko-
cyte antigen (HLA) haplotype analysis ( fig.  2 b) and intragenic 
SNP genotyping ( fig. 2 c)  [4] . The nonsense mutation p.R1763X, 
previously identified in a DEB patient from Central Europe  [2] is 
due to a C ] T transition that affects a CpG dinucleotide. CpG di-
nucleotides are frequent sites of mutations due to hypermutabil-
ity of 5-methyl-cytosine to thymine  [5] . The occurrence of the 
same mutation in DEB patients of a different geographical origin 
suggests that the residue 1763 of the  COL7A1 represents a muta-
tion ‘hotspot’, probably due to the vulnerability of the nucleotide 
sequence.
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 Dystrophic epidermolysis bullosa (DEB) is a rare genoderma-
tosis characterized by persistent blister development on the skin 
and mucous membranes in response to minor trauma. Both au-
tosomal-dominant (MIM 131750, 131800) and autosomal-reces-
sive (RDEB; MIM 226600) forms of DEB are caused by mutations 
in the  COL7A1 gene (MIM 120120), encoding type VII collagen, 
a protein that assembles into anchoring fibrils  [1] . To date, more 
than 550 mutations, most of which are family-specific, have been 
described in the  COL7A1 gene (Human Gene Mutation Database; 
www.hgmd.cf.ac.uk). Herein, we report a  COL7A1 deletion muta-
tion in compound heterozygosity with the recurrent nonsense 
p.R1763X mutation  [2] in a Spanish patient affected with severe 
generalized RDEB. Of note, mutation R1763X occurred as a de 
novo event in our proband. 
 The patient is a 38-year-old woman born to non-consanguin-
eous parents and with no family history of skin diseases. The 
generalized cutaneous blistering with scarring from birth and 
the presence of pseudosyndactyly on the hands and feet since 
early infancy supported a clinical diagnosis of severe generalized 
RDEB ( fig. 1 a–d). Oral screening revealed ulcerations, ankylo-
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 Finally, the presence of p.R1763X mutation in the patient’s 
lymphocyte DNA, together with the generalized clinical presen-
tation, argues against somatic mosaicism and in favour of a de 
novo mutation event in a single gamete or a germline mosaicism 
of the father. De novo mutations are infrequent in RDEB and, to 
our knowledge, only two have been reported to date  [6, 7] . This 
case emphasizes the importance of mutation verification in the 
family as a part of the molecular diagnostic procedure so that de 
novo mutations can be identified and accurate genetic counseling 
provided to couples at risk of recurrence. The risk of de novo mu-
tations in DEB, although small, should be considered when plan-
ning prenatal diagnosis.
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 Fig. 1. Clinical and histopathological features.  a–c Characteristic 
cutaneous blistering with scarring of left shoulder ( a ), sacral area 
( b ) and forearm ( c ).  d Pseudosyndactyly and mitten deformity of 
the left hand.  e Severe microstomia with tooth deformities and 
caries.  f Ocular findings: corneal scarring and blistering of the 
lower lid.  g SCC on the right hand stump.  h Panoramic view of a 
section from the tumor shown in  g . Several tumoral masses with 
an aggressive pattern of infiltration into the adipose tissue are 
depicted. The masses have minimal cornification, but present ex-
tensive hemorrhagic foci. HE.  i Higher magnification of the same 
tumor showing atypical keratinocytes with marked nuclear poly-
morphism, cellular dyskeratosis and minimal areas of keratiniza-
tion. Dilated blood vessels and hemorrhage are seen throughout 
the tumor. Small foci of clear cells can also be observed.  j , k Indi-
rect immunofluorescence shows the absence of collagen VII in the 
blister patient’s biopsy ( j ) versus the normal control’s biopsy ( k ). 
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 Fig. 2. Molecular characterization of the proband.  a C ] G trans-
version at nucleotide position 5287 leading to the missense mu-
tation (p.R1763X) falls in exon 60 of the COL7A1 gene. The 
c.6266CCCC deletion (c.6266_6269del) in exon 75 leads to a pre-
mature termination codon in exon 82.  b Pedigree with haplotype 
assignment of HLA typing results of the family. The proband in-
herited one HLA haplotype from each parent.  c Haplotyping assay 
based on intragenic SNP selection shows that the haplotype 7 
(H7) cosegregated with the deletion mutation inherited from her 
mother. The haplotype 1 (H1) was inherited from the father who 
does not carry the R1763X mutation. 
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